1. Introduction {#sec1}
===============

Eyebright,*Euphrasia rostkoviana* Hayne (Scrophulariaceae), has been used in Europe for centuries as a traditional medicine for treatment of various diseases. Decoctions and infusions of flowering aerial parts are used against dry cough, hoarseness, symptomatic treatment of cold, earache, and headache, hay fever, purulent skin lesion, or catarrhal diseases of the intestinal tract, but especially as eyewash to treat and prevent eye disorders such as conjunctivitis, blepharitis, eye fatigue, purulent ocular inflammation, and sties \[[@B1]--[@B3]\]. The use of eyebright tea has also been reported in ethnoveterinary medicine for cow eye infection treatment \[[@B4]\]. Despite centuries of the traditional use for the treatment of eye ailments, there has been only one prospective cohort trial carried out confirming the efficacy of*Euphrasia* eye drops in the treatment of conjunctivitis \[[@B5]\] and a single clinical study investigating the effect of local application of the eye drops on antibiotic consumption in neonates \[[@B6]\]. Moreover, until the recent reports on anticandidal \[[@B7]\] and antibacterial activity \[[@B8]\] of some*Euphrasia* extracts, the spectrum of antimicrobial action has been completely unknown.

The therapeutic effect of*E. rostkoviana* can be attributed mainly to its antioxidant, anti-inflammatory, and antimicrobial activity \[[@B2], [@B4], [@B8], [@B9]\]. Among the compounds previously identified in*E. rostkoviana* extracts \[[@B8]--[@B10]\], apigenin, luteolin, kaempferol, quercetin, caffeic acid, coumaric acid, and rosmarinic acid may be responsible for the antimicrobial action. Although the presence of essential oil (EO) in*E. officinalis* L. \[[@B11]\] and*E. stricta* Kunt \[[@B12]\] has previously been reported, the composition and bioactivity of the*E. rostkoviana* EO are unknown. Therefore, in this study, we investigated the chemical composition and antimicrobial activity of the eyebright EO against the panel of three Gram-positive bacteria (*Enterococcus faecalis*,*Staphylococcus aureus*, and*S. epidermidis*) and three Gram-negative bacteria (*Escherichia coli*,*Klebsiella pneumoniae*, and*Pseudomonas aeruginosa*), and one yeast (*Candida albicans*), organisms commonly associated with eye infections.

2. Material and Methods {#sec2}
=======================

2.1. Chemicals and Plant Material {#sec2.1}
---------------------------------

The authentic standards borneol, camphor, carvacrol, carvone, caryophyllene, p-cymene, estragole, eucalyptol, limonene, linalool, menthol, menthone, *β*-myrcene, *γ*-terpinene, and thymol for EO components identification as well as the control antibiotics ciprofloxacin and tioconazole were purchased from Sigma-Aldrich (Prague, Czech Republic). Hexane (Merck, Prague, Czech Republic), dimethyl sulfoxide (DMSO) (Lach-Ner, Neratovice, Czech Republic), and Tween 80 (Sigma-Aldrich, Prague, Czech Republic) were used as solvents. The plant material used for the EO distillation was purchased from commercial sources (F-DENTAL, Hodonín, Czech Republic). The EO was extracted by hydrodistillation using Clevenger type apparatus.

2.2. Chemical Analysis of the EO by Gas Chromatography-Mass Spectrometry (GC-MS) {#sec2.2}
--------------------------------------------------------------------------------

The*E. rostkoviana* EO was analyzed by GC-MS using Agilent 7890A GC coupled to Agilent 5975C single-quadrupole mass detector equipped with a HP-5MS column (30 m × 0.25 mm, 0.25 *μ*m film) from Agilent (Santa Clara, CA, USA). Hexane was used as a solvent and the sample volume of 1 *μ*L was injected in split mode (ratio 20 : 1) into the injector heated to 250°C. The starting oven temperature was set at 60°C for 3 min, programmed to 230°C at a rate of 3°C/min, and then kept constant for 10 min. Helium was used as carrier gas with the flow rate of 1 mL/min. The MS analysis was carried out in full-scan mode and the electron ionization energy was set at 70 eV. The identification of individual components was based on the comparison of their mass spectra and relative retention indices with the National Institute of Standards and Technology Library (NIST, USA) and literature \[[@B13]\], as well as coinjection of authentic standard.

2.3. Bacterial Strains and Cultivation Media {#sec2.3}
--------------------------------------------

The standard strains of three Gram-positive bacteria*Enterococcus faecalis* ATCC 29212,*Staphylococcus aureus* ATCC 29213, and*S. epidermidis* ATCC 12228, three Gram-negative bacteria*Escherichia coli* ATCC 25922,*Klebsiella pneumoniae* ATCC 700603, and*Pseudomonas aeruginosa* ATCC 27853, and one yeast*Candida albicans* ATCC 10231 were obtained from Oxoid (Basingstoke, United Kingdom). Cation adjusted Mueller-Hinton broth (MHB) and Sabouraud dextrose broth (SDB) were used as cultivation media for antibacterial and antifungal microdilution assay, respectively, and were equilibrated with Tris-buffered saline (Sigma-Aldrich, Prague, Czech Republic). Mueller-Hinton agar (MHA) and Sabouraud dextrose agar (SDA) were used for subsequent determination of bactericidal and fungicidal concentrations, respectively. All media were purchased from Oxoid (Basingstoke, United Kingdom).

2.4. Minimum Inhibitory Concentration (MIC) Determination {#sec2.4}
---------------------------------------------------------

The MICs were determined using the*in vitro* broth microdilution method following the guidelines of Clinical and Laboratory Standards Institute (CLSI) \[[@B14], [@B15]\] modified according to the recommendations proposed for effective assessment of the anti-infective potential of natural products \[[@B16]\] using 96-well microtiter plates. Briefly, the EO was dissolved in DMSO with addition of Tween 80 and two-fold serial dilutions were prepared in MHB for bacteria and in SDB for the yeast whereas the concentrations tested ranged from 4 to 2048 *μ*g/mL. The inoculum was prepared from overnight cultures so that the initial CFU concentrations in the microplates were 5 × 10^5^ and 2 × 10^3^ CFU/mL for bacteria and yeast, respectively. The inoculated plates were examined after 24 h of incubation at 35°C and once more after 48 h in case of*C. albicans*. The microbial growth was measured spectrophotometrically by Multiscan Ascent Microplate Photometer (Thermo Fisher Scientific, Waltham, USA) at 405 nm. MICs were expressed as the lowest concentrations able to inhibit ≥ 80% of bacterial growth compared to the positive growth control. The experiments were performed in triplicate in three independent tests and median values were used for MICs calculation. Due to the recently reported possibility of EO volatile components\' influence on the microbial growth in adjoining wells \[[@B17]\], positive growth control rows were inserted in between the EO dilution rows to detect eventual growth influence. The solvents used did not inhibit the bacterial growth at concentrations tested. Ciprofloxacin and tioconazole were used as reference antibiotics for bacteria and yeast, respectively.

2.5. Minimum Bactericidal Concentration (MBC) and Minimum Fungicidal Concentration(MFC) Determination {#sec2.5}
-----------------------------------------------------------------------------------------------------

The aliquots of 20 *μ*L were transferred from each well without microbial growth to the MHA plates (SDA plates for*C. albicans*) after 24 h and 48 h of incubation of bacteria and yeast tested, respectively. The plates were then incubated for 24 h at 35°C. The MBC and MFC were evaluated as ≥99.9% decrease in CFU comparing to inoculum, all performed in triplicate in three independent tests.

3. Results and Discussion {#sec3}
=========================

3.1. Chemical Characterization of Oils and Bioactive Fractions Constituents {#sec3.1}
---------------------------------------------------------------------------

The EO hydrodistillation by Clevenger-type apparatus yielded 0.02% (w/v) of yellowish-brown oil that tends to solidify at room temperature which is probably caused by high proportion of fatty acids (32.23% in total). GC-MS analysis of the EO revealed the presence of more than 70 constituents, with palmitic acid (18.47%) being the most abundant component followed by thymol (7.97%), myristic acid (4.71%), linalool (4.65%), anethole (4.09%), linolenic acid (3.81%), hexahydrofarnesyl acetone (3.16%), lauric acid (2.79%), *α*-terpineol (2.39%), and borneol (2.39%). The main compounds are shown also in the chromatogram ([Figure 1](#fig1){ref-type="fig"}) and the complete list of EO constituents is presented in [Table 1](#tab1){ref-type="table"}.

The high content of fatty acids has previously been found in the*E. stricta* EO (25.7% in total) also with the highest proportion of palmitic acid (20.3%) and myristic acid (3.9%) \[[@B12]\]. However, there is no other compound present in significant amount that would indicate the relatedness of these two*Euphrasia* species.

3.2. Antimicrobial Activity {#sec3.2}
---------------------------

The*E. rostkoviana* EO showed activity against six out of seven organisms tested with MICs ranging from 512 to 2048 *μ*g/mL. The Gram-positive bacteria were more sensitive than the Gram-negative ones and the yeast whereas*P. aeruginosa* was the only organism that was not inhibited by the oil at the highest concentrations tested. The MICs, MBCs, and MFCs of the EO against all microorganisms tested are summarized in [Table 2](#tab2){ref-type="table"}. The active concentrations are comparable to those previously reported for, for example, EOs of*Artemisia annua, Eucalyptus globulus*,*Mentha suaveolens*,*Myrtus communis*,*Ocimum basilicum*, or*Thymus vulgaris*, especially in the case of anticandidal activity \[[@B18]--[@B20]\]. The oil was also more effective than*E. rostkoviana* extracts tested by Teixeira and Silva \[[@B8]\] against*E. coli*,*E. faecalis*,*S. aureus*, and*S. epidermidis*. The MICs of the reference antibiotics against the bacteria and yeast susceptible to the*E. rostkoviana* EO were in accordance with the CLSI acceptable limits and previous reports, respectively \[[@B21]--[@B23]\].

Since the content of the main EO constituent palmitic acid does not exceed 20% and there are more than 10 other antimicrobially active compounds ranging from 1 to 8% it is difficult to suggest the main agents responsible for the*E. rostkoviana* EO antimicrobial effect. Palmitic acid has been previously identified as the major compound of fractions active against Gram-negative, but not Gram-positive, bacteria \[[@B24]\]. On the other hand, medium-chain saturated fatty acids and long-chain unsaturated fatty acids are known to inhibit especially Gram-positive bacteria \[[@B25]\]. Moreover, lauric acid exerts also activity against a number of fungi \[[@B26]\]. Thus the antimicrobial activity of the EO is probably due to a complex action of the antimicrobial fatty acids with the other well-known antimicrobial compounds identified in the EO such as anethole, borneol, camphor, carvacrol, linalool, menthol, *α*-terpineol, or thymol.

4. Conclusions {#sec4}
==============

In conclusion, the chemical analysis revealed a number of antimicrobially active substances present in the*E. rostkoviana* EO and its antifungal and antibacterial activity against Gram-positive as well as Gram-negative bacteria was confirmed. To the best of our knowledge, this is the first report on the composition and antimicrobial activity of*E. rostkoviana* EO.
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![Typical chromatogram of*Euphrasia rostkoviana* essential oil. The main components are labeled according to the order of their retention times. (12) Linalool; (22) *α*-terpineol; (34) anethole; (36) thymol; (37) carvacrol; (58) lauric acid; (66) myristic acid; (67) hexahydrofarnesyl acetone; (70) palmitic acid; (73) linolenic acid.](ECAM2015-734101.001){#fig1}

###### 

Chemical composition of *Euphrasia rostkoviana* Hayne essential oil.

  Peak number   Component              RI     Area (%)^∗^   ID        Peak number   Component                   RI     Area (%)    ID
  ------------- ---------------------- ------ ------------- --------- ------------- --------------------------- ------ ----------- ---------
  1             1-Hexanol^d^           ---    0.10          a         41            Damascenone                 1385   0.56        a, b
  2             1-Octen-3-ol           981    1.82          a, b      42            Methyl eugenol              1406   0.23        a, b
  3             *β*-Myrcene            992    0.14          a, b, c   43            Caryophyllene               1419   1.28        a, b, c
  4             3-Octanol              996    0.13          a, b      44            Geranyl acetone             1455   0.89        a, b
  5             p-Cymene               1027   0.81          a, b, c   45            Trans-*β*-farnesene         1460   0.13        a, b
  6             Limonene               1032   0.34          a, b, c   46            Alloaromadendrene           1462   0.12        a, b
  7             Eucalyptol             1034   0.25          a, b, c   47            *γ*-Muurolene               1478   0.25        a, b
  8             *γ*-Terpinene          1062   0.34          a, b, c   48            Germacrene D                1482   0.31        a, b
  9             Sabinene hydrate       1070   0.14          a, b      49            Curcumene                   1484   1.21        a, b
  10            1-Octanol              1074   0.40          a, b      50            Trans-*β*-ionone            1487   1.53        a, b
  11            3,5-Octadienone^d^     1094   0.16          a, b      51            Valencene                   1493   0.13        a, b
  12            Linalool               1101   4.65          a, b, c   52            *α*-Selinene^d^             1495   0.17        a, b
  13            *α*-Thujone            1106   0.88          a, b      53            Epizonarene^d^              1498   0.26        a, b
  14            *β*-Thujone            1118   0.48          a, b      54            *α*-Muurolene               1500   0.18        a, b
  15            Camphor                1146   1.00          a, b, c   55            *β*-Bisabolene              1510   0.94        a, b
  16            Menthone               1156   1.98          a, b, c   56            *γ*-Cadinene                1515   0.40        a, b
  17            2-Nonenal, (E)-        1163   0.10          a, b      57            Nerolidol^d^                1566   0.10        a, b
  18            Borneol                1168   2.39          a, b, c   58            Lauric acid                 1574   2.79        a, b
  19            (+/−)Lavandulol        1170   0.16          a, b      59            Spathulenol                 1578   0.61        a, b
  20            Menthol                1175   2.02          a, b, c   60            Caryophyllene oxide         1583   1.47        a, b
  21            4-Terpineol            1179   1.13          a, b      61            Pseudoionone^d^             1587   0.18        a, b
  22            *α*-Terpineol          1191   2.39          a, b      62            Humulene epoxide II         1609   0.25        a, b
  23            Estragole              1199   0.34          a, b, c   63            Longifolenaldehyde^d^       1613   0.20        a, b
  24            Decanal                1207   0.15          a, b      64            *τ*-Cadinol                 1643   0.18        a, b
  25            *β*-Cyclocitral^d^     1222   0.21          a, b      65            *β*-Eudesmol                1651   0.13        a, b
  26            Thymol methyl ether    1238   0.75          a, b      66            Myristic acid               1771   4.71        a, b
  27            Cumin aldehyde         1242   0.23          a, b      67            Hexahydrofarnesyl acetone   1847   3.16        a, b
  28            Neral                  1244   0.14          a, b      68            Pentadecanoic acid          1865   0.28        a, b
  29            Carvone                1246   1.28          a, b, c   69            Farnesyl acetone            1919   0.50        a, b
  30            Piperitone             1256   0.18          a, b      70            Palmitic acid               1977   18.47       a, b
  31            Geraniol               1258   0.79          a, b      71            Phytol^d^                   2114   0.12        a, b
  32            Trans-2-decenal^d^     1264   0.11          a, b      72            Linoleic acid               2143   1.90        a, b
  33            Geranial               1273   0.15          a, b      73            Linolenic acid              2148   3.81        a, b
  34            Anethole               1287   4.09          a, b      74            Tricosane                   2300   1.79        a, b
  35            Safrole                1289   0.21          a, b      75            Tetracosane                 2400   0.16        a, b
  36            Thymol                 1295   7.97          a, b, c   76            Pentacosane                 2500   1.36        a, b
  37            Carvacrol              1304   1.96          a, b, c                                                                 
  38            (E,E)-2,4-Decadienal   1318   0.21          a, b                    Total identified                   **98.91**    
  39            Capric acid            1374   0.26          a, b                                                                    
  40            *α*-Copaene            1377   0.15          a, b                                                                    

R: retention indices relative to n-alkanes on HP-5MS capillary column (30 m × 0.25 mm, 0.25 *μ*m); ^∗^peak area relative to total peak area in %; ID: identification method; a: identification based on mass spectra matching; b: identification based on retention index; c: identification based on coinjection of authentic sample; d: tentative identification.

###### 

The inhibitory and cidal concentrations of *E. rostkoviana* essential oil.

  Microorganism                  *Euphrasia rostkoviana* EO   CIP    TIO                              
  ------------------------------ ---------------------------- ------ -------- ------ -------- ------- -------
  *Enterococcus faecalis*        512                          ---    128      ---    1024     0.5     ---
  *Staphylococcus aureus*        512                          ---    128      ---    \>2048   0.5     ---
  *Staphylococcus epidermidis*   512                          ---    256      ---    \>2048   0.25    ---
  *Klebsiella pneumoniae*        2048                         ---    1024     ---    \>2048   0.125   ---
  *Escherichia coli*             2048                         ---    1024     ---    \>2048   0.015   ---
  *Pseudomonas aeruginosa*       \>2048                       ---    \>2048   ---    \>2048   0.125   ---
  *Candida albicans*             128                          1024   128      1024   2048     ---     0.063

^∗^The growth inhibition was measured after 24 h and 48 h of incubation in case of *C. albicans*; EO: essential oil; CIP: ciprofloxacin; TIO: tioconazole; MIC: minimum inhibitory concentration; IC50: inhibitory concentration causing ≥50% of bacterial growth; MBC: minimum bactericidal concentration; MFC: minimum fungicidal concentration.
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